Back to Search
Start Over
[Malaria--chemoprophylaxis 2001].
- Source :
-
Therapeutische Umschau. Revue therapeutique [Ther Umsch] 2001 Jun; Vol. 58 (6), pp. 347-51. - Publication Year :
- 2001
-
Abstract
- An estimated 20,000 to 30,000 cases of imported malaria are annually diagnosed in industrialised countries. Some 700 of them concern Swiss travellers and foreign guests. Exposure prophylaxis and chemoprophylaxis for high risk destinations lower the risk of malarial disease. The latter is defined as regular intake of antimalarial drugs in subtherapeutic dosage in order to suppress the development of clinical disease. Drugs are usually taken from one week before travel until four weeks after return from an endemic area. Mefloquine, doxycycline, chloroquine plus proguanil, and presumably soon also atovaquone plus proguanil are available in Switzerland for chemoprophylaxis.
- Subjects :
- Africa epidemiology
Asia epidemiology
Atovaquone
Chloroquine therapeutic use
Contraindications
Doxycycline therapeutic use
Drug Combinations
Drug Therapy, Combination
Humans
Malaria epidemiology
Malaria, Falciparum prevention & control
Mefloquine therapeutic use
Naphthoquinones therapeutic use
Practice Guidelines as Topic
Proguanil therapeutic use
South America epidemiology
Switzerland
Antimalarials therapeutic use
Malaria prevention & control
Travel
Subjects
Details
- Language :
- German
- ISSN :
- 0040-5930
- Volume :
- 58
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Therapeutische Umschau. Revue therapeutique
- Publication Type :
- Academic Journal
- Accession number :
- 11441694
- Full Text :
- https://doi.org/10.1024/0040-5930.58.6.347